Last reviewed · How we verify
hyperbaric bupivacaine and dexmedetomidine
At a glance
| Generic name | hyperbaric bupivacaine and dexmedetomidine |
|---|---|
| Sponsor | Lady Reading Hospital, Pakistan |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery (PHASE2)
- Spinal Analgesia in Labour Pain (PHASE1)
- Comparison Between Intrathecal Magnesium Sulphate & Dexmedetomidine in DHS (PHASE3)
- Comparative Dose-Response of Intrathecal Dexmedetomidine for Post-Spinal Shivering (PHASE3)
- Intrathecal Dexmedetomidine vs Epinephrine (PHASE4)
- Comparative Analysis of Intraoperative Effect Dexmedetomidine and Fentanyl as an Adjuvant to Heavy Bupivacaine in Spinal Anaesthesia in Lower Limb Orthopedic Surgeries to Evaluate the Hemodynamic Stability and Onset and Duration of Motor Block of Using Intrathecal Dexmedetomidine and Fentanyl (PHASE4)
- Effect of Dexmedetomidine on the Quality of Recovery in Parturients Undergoing Elective Caesarean Sections (PHASE4)
- ED50 of Dexmedetomidine as an Adjuvant to 0.5% Hyperbaric Bupivacaine 12.5 mg for Spinal Anesthesia in Hip and Knee Surgery: An Up-and-Down Method Approach (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: